Suppr超能文献

低级别和高级别嗅神经母细胞瘤具有明显不同的自然病史和转归。

Low- and high-grade esthesioneuroblastomas display a distinct natural history and outcome.

机构信息

Department of Radiotherapy, Institut de Cancérologie Gustave Roussy, Villejuif, France.

出版信息

Eur J Cancer. 2013 Apr;49(6):1324-34. doi: 10.1016/j.ejca.2012.12.008. Epub 2013 Jan 10.

Abstract

PURPOSE

Esthesioneuroblastomas, also called olfactory neuroblastomas (ENB) represent a rare sinonasal neurectodermal tumour which prognostic factors are unsteadily described.

PATIENTS AND METHODS

Clinical and pathological characteristics were analysed in patients treated at Gustave Roussy Institute between 1979 and 2009.

RESULTS

Out of 63 patients, 19 patients were reclassified and 44 patients were eligible for the analysis. Multivariate analysis revealed that T staging of the modified Dulguerov TNM staging and Hyams grade>III (that we termed high-grade ENB) were the only independent prognostic factors for overall survival (OS). As compared to patients with low-grade ENB (Hyams grade ≤ III), patients with high-grade ENB have higher T4 staging (p=0.02), have frequent lymph node involvement (p=0.009) and are more often unresectable (p=0.005). Resected patients with high-grade ENB frequently displayed mainly leptomeningeal metastasis (n=4/6) in contrast to patients with low-grade ENB who typically experience late loco-regional recurrence (n=10/25). With a median follow-up of 9.6 years, median DFS and OS for resected low-grade ENB were 5.4 and 20.5 years, respectively. Conversely, median DFS and OS for high-grade ENB were 1.5 and 2.5 years, respectively.

CONCLUSION

Low and high-grade ENB display distinct patterns at presentation and relapse, leading to different prognosis. Therefore, they may be regarded as distinct entities.

摘要

目的

嗅神经母细胞瘤,又称嗅神经母细胞瘤(ENB),是一种罕见的发生于鼻腔鼻窦的神经外胚层肿瘤,其预后因素尚未得到明确描述。

患者与方法

分析了 1979 年至 2009 年在古斯塔夫·鲁西研究所接受治疗的患者的临床和病理特征。

结果

在 63 名患者中,19 名患者被重新分类,44 名患者符合分析要求。多变量分析显示,改良 Dulguerov TNM 分期的 T 分期和 Hyams 分级>III(我们称之为高级别 ENB)是总生存(OS)的唯一独立预后因素。与低级别 ENB(Hyams 分级≤III)患者相比,高级别 ENB 患者的 T4 分期更高(p=0.02),淋巴结受累更频繁(p=0.009),且往往无法切除(p=0.005)。高级别 ENB 切除患者主要表现为软脑膜转移(n=4/6),而低级别 ENB 患者通常表现为局部区域复发(n=10/25)。中位随访 9.6 年后,切除的低级别 ENB 的中位无进展生存期(DFS)和总生存期(OS)分别为 5.4 年和 20.5 年,而高级别 ENB 的中位 DFS 和 OS 分别为 1.5 年和 2.5 年。

结论

低级别和高级别 ENB 在发病和复发时表现出不同的模式,导致不同的预后。因此,它们可能被视为不同的实体。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验